Solara Active Pharma Sciences informs about outcome of board meting

17 Dec 2025 Evaluate

Solara Active Pharma Sciences has informed that the Board of Directors of the Company based on the recommendation of the Nomination and Remuneration Committee, at its meeting held today i.e. December 17, 2025, transacted and approved the appointment of Mohanraj S(DIN: 08420411) as an Additional - Executive Director and Whole -Time Director for a period of 3 years with effect from January 1, 2026 subject to approval of the Shareholders of the Company. Further, in terms of BSE Circular bearing Reference No. LIST/COMP/14/2018-19 and NSE Circular bearing Reference No. NSE/CML/2018/24 dated June 20, 2018, they confirmed that Mohanraj S is not debarred from accessing capital markets and /or restrained from holding the office of Director by virtue of any order of the Securities and Exchange Board of India (“SEBI”) or any other such authority. 

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

462.40 1.30 (0.28%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×